Michael Saag offers a unique perspective on COVID-19. Not only is Saag clinically engaged in the treatment of COVID patients at an outpatient clinic but he also contracted SARS-CoV-2 last March at a conference in Boston—offering the perspective of both a physician and patient.
And now, he will bring that perspective to the ºÚÁϳԹÏÍø SARS-CoV-2 Task Force Steering Committee’s virtual retreat on Tuesday, Nov. 17, from 9 a.m. to 4 p.m. The ºÚÁϳԹÏÍø SARS-CoV-2 Task Force was initiated in March 2020 with a strong collaborative response from ºÚÁϳԹÏÍø investigators to control the pandemic.
, will deliver the keynote address at the retreat.
Following Saag’s presentation, each Task Force working group will have an hour for presentations with a Q&A session. The retreat will end with a roundtable discussion.
Saag is the principal investigator on the Center for AIDS Research Network of Integrated Clinical Systems (CNICS), which is engaged in a national study of the impact of COVID-19 on the 22,000-plus active participants in the CNICS cohort, and of which ºÚÁϳԹÏÍø School of Medicine is a member. He is also serving on the Data and Safety Monitoring Board of the national I-SPY2 adaptive clinical trial, a National Institutes of Health-sponsored study to evaluate multiple interventions for hospitalized COVID-19 patients in the US.
The retreat is open to ºÚÁϳԹÏÍø investigators, faculty, fellows and research staff. Registration is required.
Alumni, donors and community participants can email cwru-covid-taskforce@case.edu to register. Individuals can also direct any questions to cwru-covid-taskforce@case.edu.
